组C 贝塔血液溶解性链球菌 致死性肺炎,并发症为肺肺胸炎
William McLean1, Daisy Port1, Daniel Sims1
1Royal Surrey County Hospital, Guildford, UK.
Case reports in pulmonology
|November 10, 2025
概括
群Cβ血解性链球菌 (GCBHS) 可以导致严重的死性肺炎,这是一个罕见的疾病. 这一案例突出了一个年轻的男性患有肺肺胸部,败血症和ARDS,强调了潜在的动物传染病联系和需要积极管理的需要.
科学领域:
- 医学微生物学 医学微生物学
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
背景情况:
- 群Cβ血溶性链球菌 (GCBHS) 是侵袭性感染的不常见原因,通常与高死亡率有关.
- 虽然GCBHS可以引起肺炎,但严重的死性肺炎是非常罕见的,之前没有报告过由pyopneumothorax复杂的病例.
- 以前的文献表明,GCBHS感染与男性性别以及动物暴露之间的潜在关联.
研究的目的:
- 报告一个罕见的严重死性肺炎病例,由GCBHS引起,并由年轻男性的肺肺胸部复杂.
- 要突出临床表现,诊断挑战和这种严重的GCBHS感染的管理.
- 讨论与侵袭性GCBHS感染相关的潜在动物性疾病影响和风险因素.
主要方法:
- 一份病例报告详细介绍了一名20岁的男性农业学生,没有先前的病史,出现严重肺炎和败血症的症状.
- 诊断工作包括血液培养,胸部计算机断层扫描 (CT) 和随后的微生物识别 *Streptococcus dysgalactiae *亚种. *equisimilis* (SDSE) 作为病原体.
- 治疗包括重症监护,机械通风,双侧胸部排水和双侧视频辅助胸部手术 (VATS) 与洗.
主要成果:
- 这位患者出现了败血症,急性损伤 (AKI),扩散性血管内凝血 (DIC) 和急性呼吸困扰综合征 (ARDS).
- 胸部CT显示了双边的肺肺胸部和空洞化肺结节,在连续成像上进展.
- 血液培养证实了GCBHS,被确定为*Streptococcus dysgalactiae*亚种. *equisimilis* (SDSE). *equisimilis* (SDSE). *equisimilis* (SDSE). *equisimilis* (SDSE). *equisimilis* (SDSE). *equisimilis) *equisimilis* (SDSE) *equisimilis* (SDSE) *equisimilis* (SDSE) *equisimilis* (SDSE) *equisimilis* (SDSE) *equisimilis* (SDSE) *equisimilis* (SDSE) *equisimilis) *equisimilis* (SDSE) *equisimilis* (SDSE) *equisimilis* (SDSE) *equisimilis* (SDSE) *equisimilis) *equisimilis* (SDSE) *equisimilis* (SDSE) *equisimilis)
结论:
- 侵袭性GCBHS感染,特别是带有肺肺胸炎的死性肺炎,很少见,但携带高死亡风险,并与长时间住院有关.
- 这一案例强调了GCBHS的潜在动物传染性质,患者是一名农业学生.
- 积极的管理,包括胸部干预,对于改善严重GCBHS感染的结果至关重要.
相关概念视频
Pneumonia III: Complications and Assessment
768
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
768
Pneumonia I: Introduction
712
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
712
Pneumonia II: Pathophysiology
2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
Pneumothorax-I
1.1K
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
1.1K
Pneumonia IV: Management
740
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
740
Pneumothorax-II
874
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
874


